Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,586.41
(
-0.58%
)
US TECH 100
23,582.40
(
-0.90%
)
Dow Jones
45,889.85
(
-0.73%
)
Brent Oil
104.29
(
-2.15%
)
Bitcoin
69,800.91
(
-2.02%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 63937

Monday, 07/07/2008 2:31:40 AM

Monday, July 07, 2008 2:31:40 AM

Post# of 257259
Recent Biotech Buyouts at a Large Premium

[Added APPX.]
 
 Acquired         Premium    Deal         iHub  
 Company  Buyer   to Market  Value  Date  Reference  
 KOSN     BMY       233%     $190M  5/08  #msg-29647147 
 COLY     PFE       167%     $165M 11/07  #msg-24600805 
 IOMI     Intercell 147%     $190M  5/08  #msg-29232165  
 BTRX     Stiefel   136%     $150M  6/08  #msg-30201906 
 ENCY     PFE       118%     $350M  2/08  #msg-26978155 
 TRCA     Ipsen     104%     $660M  6/08  #msg-29795183  
 SIRT     GSK        85%     $620M  4/08  #msg-28705020  
 Jerini   Shire     *71%     $520M  7/08  #msg-30452872 
 MLNM     Takeda     53%     $8.8B  4/08  #msg-28365383 
 APPX     Fresenius †29%     $940M  7/08  #msg-30498388 
  
 *199% premium to volume-weighted 
 price during preceding 3 months. 
  
 †Premium reaches 63% if earn-out met.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now